LLY

1,076.96

+0.06%↑

JNJ

207.49

-0.14%↓

ABBV

230.16

+0.01%↑

UNH

331.59

+1.17%↑

AZN

92.89

+0.42%↑

LLY

1,076.96

+0.06%↑

JNJ

207.49

-0.14%↓

ABBV

230.16

+0.01%↑

UNH

331.59

+1.17%↑

AZN

92.89

+0.42%↑

LLY

1,076.96

+0.06%↑

JNJ

207.49

-0.14%↓

ABBV

230.16

+0.01%↑

UNH

331.59

+1.17%↑

AZN

92.89

+0.42%↑

LLY

1,076.96

+0.06%↑

JNJ

207.49

-0.14%↓

ABBV

230.16

+0.01%↑

UNH

331.59

+1.17%↑

AZN

92.89

+0.42%↑

LLY

1,076.96

+0.06%↑

JNJ

207.49

-0.14%↓

ABBV

230.16

+0.01%↑

UNH

331.59

+1.17%↑

AZN

92.89

+0.42%↑

Inicio・Lista de Acciones・CorMedix Inc

CorMedix Inc

Cerrado

SectorSanidad

12.53 2.96

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

12.03

Máximo

12.6

Métricas clave
By Trading Economics
Ingresos	89M 109M
Ventas	65M 104M
P/B Media del Sector	5.606 78.892
BPA	0.28
Margen de beneficios	104.112
Empleados	64
EBITDA	37M 57M

Recomendaciones
By TipRanks
Recomendaciones	Compra Fuerte
Estimación a 12 Meses	+43.56% upside

Dividendos
By Dow Jones
Próximas Ganancias	24 mar 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	108M 976M
Apertura anterior	9.57
Cierre anterior	12.53

Noticias sobre sentimiento de mercado

By Acuity

23%

77%

43 / 374 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Strong Bullish Evidence

9.2 / N/A Soporte y Resistencia

CorMedix Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

24 dic 2025, 21:41 UTC

Adquisiciones, fusiones, absorciones

Nvidia to Buy Chip-Designer Groq for $20 Billion, CNBC Reports

24 dic 2025, 14:57 UTC

Adquisiciones, fusiones, absorciones

Accenture to Acquire Cabel Industry from Fibonacci Group

25 dic 2025, 23:42 UTC

Charlas de Mercado

Nikkei May Trade in Range; Yen in Focus -- Market Talk

25 dic 2025, 23:40 UTC

Charlas de Mercado

Gold Edges Higher Amid Geopolitical Risks -- Market Talk

25 dic 2025, 00:20 UTC

Adquisiciones, fusiones, absorciones

Nike Climb Boosts Dow, S&P 500 -- 2nd Update

24 dic 2025, 22:22 UTC

Adquisiciones, fusiones, absorciones

Nvidia, Groq Strike AI Tech Licensing Deal -- Barrons.com

24 dic 2025, 21:26 UTC

Adquisiciones, fusiones, absorciones

Nvidia to Buy Chip-Designer Groq for $20B, CNBC Reports

24 dic 2025, 19:35 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

24 dic 2025, 19:35 UTC

Charlas de Mercado

Treasury Yields Decline Ahead of Christmas -- Market Talk

24 dic 2025, 19:09 UTC

Charlas de Mercado

Adquisiciones, fusiones, absorciones

Global Equities Roundup: Market Talk

24 dic 2025, 19:09 UTC

Charlas de Mercado

Adquisiciones, fusiones, absorciones

ServiceNow's Armis Acquisition Shouldn't Fuel Fears That Seat-Based Model Threatened -- Market Talk

24 dic 2025, 19:06 UTC

Charlas de Mercado

Oil Futures Little Changed in Light Pre-Holiday Trade -- Market Talk

24 dic 2025, 19:03 UTC

Charlas de Mercado

U.S. Natural Gas Futures Give Back Some Gains -- Market Talk

24 dic 2025, 17:20 UTC

Charlas de Mercado

Adquisiciones, fusiones, absorciones

Tech, Media & Telecom Roundup: Market Talk

24 dic 2025, 17:20 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

24 dic 2025, 17:08 UTC

Adquisiciones, fusiones, absorciones

This Biotech Stock Soars 39%. Sanofi Is Buying It for $2.2 Billion. -- Barrons.com

24 dic 2025, 16:53 UTC

Adquisiciones, fusiones, absorciones

Nike Climb Boosts Dow, S&P 500 -- WSJ

24 dic 2025, 16:31 UTC

Charlas de Mercado

Adquisiciones, fusiones, absorciones

ServiceNow Gets Top-Tier Asset and Talent With Armis Buy -- Market Talk

24 dic 2025, 16:28 UTC

Adquisiciones, fusiones, absorciones

Lam Research Is at All-Time Highs. Its CEO Just Sold $27 Million Worth of Stock. -- Barrons.com

24 dic 2025, 16:17 UTC

Charlas de Mercado

Dollar Stable as U.S. Layoffs Remain at Bay -- Market Talk

24 dic 2025, 15:33 UTC

Adquisiciones, fusiones, absorciones

Nike Shares Get a Lift After Apple's Tim Cook Doubles His Personal Stake -- WSJ

24 dic 2025, 15:30 UTC

Adquisiciones, fusiones, absorciones

Apple CEO Tim Cook Buys $3 Million of Nike Shares. The Stock Is Rising. -- Barrons.com

24 dic 2025, 15:19 UTC

Adquisiciones, fusiones, absorciones

Apple CEO Tim Cook Buys $3 Million of Nike Shares. The Stock Is Rising. -- Barrons.com

24 dic 2025, 14:49 UTC

Adquisiciones, fusiones, absorciones

Mexico's Ollamani Sells Stake in Azteca Stadium

24 dic 2025, 14:19 UTC

Charlas de Mercado

U.S. Natural Gas Futures Move Lower After Big Jump -- Market Talk

24 dic 2025, 14:08 UTC

Adquisiciones, fusiones, absorciones

Apple CEO Tim Cook Buys $3 Million of Nike Shares. The Stock Is Rising. -- Barrons.com

24 dic 2025, 14:06 UTC

Charlas de Mercado

Oil Futures Edge Up on Geopolitical Risk Premium -- Market Talk

24 dic 2025, 13:24 UTC

Charlas de Mercado

Canada's Economy Needs More Help Amid Dismal GDP Report -- Market Talk

24 dic 2025, 12:59 UTC

Adquisiciones, fusiones, absorciones

This Biotech Stock Is Soaring. Sanofi Is Buying It for $2.2 Billion. -- Barrons.com

24 dic 2025, 12:51 UTC

Adquisiciones, fusiones, absorciones

Disney Could Be the Real Winner from the Warner Takeover Battle. Here's Why. -- Barrons.com

Comparación entre iguales

Cambio de precio

CorMedix Inc previsión

Precio Objetivo

By TipRanks

43.56% repunte

Estimación a 12 Meses

Media 17.5 USD 43.56%

Máximo 22 USD

Mínimo 14 USD

De acuerdo con 6 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para CorMedix Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

6 ratings

Comprar

Mantener

Vender

De acuerdo con 6 analistas que ofrecen calificaciones bursátiles a para CorMedix Inc Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

9.2 / N/ASoporte y Resistencia

Recent bullish events outweigh bearish events.

All events are bullish.

Sentimiento

By Acuity

43 / 374 Clasificación en Sanidad

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de CorMedix Inc

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.